In the United States, the Food and Drug Administration (FDA) is the primary regulatory authority overseeing the importation and distribution of pharmaceutical products. The FDA enforces regulations to ensure that imported drugs meet safety, efficacy, and quality standards. Key legislation governing pharmaceutical imports includes the Federal Food, Drug, and Cosmetic Act, which outlines the requirements for drug approval, labeling, and manufacturing practices.
The marketing authorization pathway for Indian generics involves several steps:
1. Abbreviated New Drug Application (ANDA): Indian manufacturers must submit an ANDA to the FDA, demonstrating that their generic product is bioequivalent to the reference listed drug.
2. Good Manufacturing Practice (GMP) Compliance: Manufacturers must comply with FDA's GMP regulations, ensuring that products are consistently produced and controlled.
3. Inspection and Approval: The FDA conducts inspections of manufacturing facilities to verify compliance with GMP and other regulatory requirements.
4. Labeling Requirements: Products must have labeling that meets FDA standards, including accurate information about the drug's use, dosage, and potential side effects.
